Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). The Lancet. Oncology. 2018; 19: p.27-39. doi:10.1016/S1470-2045(17)30777-5Article